A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 332 participants.
Also called NCT07301034
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 332 participants
- Sponsor
- Registry
-
NCT07301034
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Denmark, Italy, Netherlands, Spain, Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT07301034. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-18 (actual); primary completion 2028-11-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
- Acronym
- ZEPHYR
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Ziltivekimab
- Intervention (Drug)
- Ziltivekimab Placebo
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07301034- Content hash
0b0a7534250f5b6f8328e851da9011a86782d335c0d70e03eb758c406f6e017b